TELO
Telomir Pharmaceuticals, Inc. Common Stock
NASDAQHealthcareBiotechnologyUS
Rating:C-
Company Profile
CEO
Erez Aminov
IPO Date
2019-04-09
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Telomir Pharmaceuticals, Inc. Common Stock
CEO
Erez Aminov
IPO Date
2019-04-09
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| 1,960,170 |
| $5.02 |
| 22 May 2026 | Aminov Erez | director, officer: CEO and Chairman | A-Award | Acquired | 2,000,000 | $1.30 |
| 22 May 2026 | Aminov Erez | director, officer: CEO and Chairman | D-Return | Disposed | 2,000,000 | $2.10 |
| 22 May 2026 | Whalen Matthew Pratt | director | A-Award | Acquired | 25,000 | $1.30 |
| 22 May 2026 | Whalen Matthew Pratt | director | D-Return | Disposed | 25,000 | $5.02 |
| 22 May 2026 | MacPherson Edward Clouston | director | A-Award | Acquired | 25,000 | $1.30 |
| 22 May 2026 | MacPherson Edward Clouston | director | D-Return | Disposed | 25,000 | $5.02 |
| 22 May 2026 | Del Giudice Matthew Paul | director | A-Award | Acquired | 25,000 | $1.30 |
| 22 May 2026 | Del Giudice Matthew Paul | director | D-Return | Disposed | 25,000 | $5.02 |